PlsY is a membrane-associated enzyme critical for phospholipid biosynthesis. It catalyzes the first step in glycerolipid formation, converting glycerol-3-phosphate and acyl-phosphate to lysophosphatidic acid, a precursor for membrane lipids . In N. meningitidis, phospholipids are essential for maintaining membrane integrity and facilitating interactions with host cells during infection.
Recombinant PlsY from serogroups A and C is produced in E. coli with an N-terminal His tag for purification. Key characteristics include:
Expression: High-yield soluble expression under optimized conditions .
Functionality: Retains enzymatic activity in vitro, confirmed by acyltransferase assays .
Potential Use: Serves as a tool for studying lipid metabolism in Neisseria and screening antimicrobial agents targeting membrane biosynthesis.
Notably, MenB’s lipid metabolism relies on alternative pathways, possibly involving exogenous fatty acid uptake or non-PlsY acyltransferases .
MenB-Specific Challenges: The apparent absence of plsY in MenB raises questions about compensatory mechanisms for phospholipid synthesis. This gap highlights the need for deeper genomic and proteomic analyses of MenB strains .
Vaccine Development: While PlsY is not a component of current MenB vaccines (e.g., Bexsero, Trumenba), understanding lipid biosynthesis could inform novel therapeutic strategies .
Functional Studies: Heterologous expression of MenB homologs (if identified) in E. coli to confirm enzymatic activity.
Structural Biology: Cryo-EM or X-ray crystallography to resolve PlsY’s catalytic mechanism across serogroups.
This enzyme catalyzes the transfer of an acyl group from acyl-phosphate (acyl-PO4) to glycerol-3-phosphate (G3P), resulting in the formation of lysophosphatidic acid (LPA). While it utilizes acyl-phosphate as the fatty acyl donor, it does not utilize acyl-CoA or acyl-ACP.
KEGG: nme:NMB1062
STRING: 122586.NMB1062